Synthesis of Fluorescent Alanines
125.03 (CH), 125.84 (CH), 126.98 (CH), 127.44 (CH), 127.68 (CH), Methyl 2-[2-(tert-Butoxycarbonylamino)-3-phenylpropanamido]-3-
128.63 (CH), 129.52 (C), 130.46 (C), 130.85 (C), 131.30 (C), 131.88 (phenanthren-9-yl)propanoate (4b): The general procedure described
(C), 151.54 (C=O), 170.93 (C=O) ppm. HMRS (ESI): calcd. for above was applied with compound 2 (0.2 mmol, 70.0 mg) and 9-
C30H33NNaO6 526.22056; found 526.2205.
phenanthraneboronic acid (0.8 mmol, 177 mg) to give compound
4b (57.0 mg, 54%).[2c]
Methyl 2-{tert-Butoxycarbonyl[(4-nitrobenzyloxy)carbonyl]amino}-
3-(naphthalen-1-yl)propanoate (5): The general procedure described
above was applied with methyl 2-{tert-butoxycarbonyl[(4-nitro-
benzyloxy)carbonyl]amino}acrylate (0.2 mmol, 76 mg) and 1-
Methyl 2-[2-(tert-Butoxycarbonylamino)-3-phenylpropanamido]-3-
(pyren-1-yl)propanoate (4c): The general procedure described above
was applied with compound 2 (0.2 mmol, 70.0 mg) and 1-py-
reneboronic acid (0.8 mmol, 197 mg) to give compound 4c
naphthaleneboronic acid (0.8 mmol, 138 mg) to give compound 5
1
(61.3 mg, 60%) as an oil. H NMR (300 MHz, CDCl3): δ = 1.17 (37.6 mg, 34%) as a white solid. M.p. 185.0–186.0 °C (from ethyl
(s, 9 H, CH3), 3.48–3.57 (dd, J = 11.1 and 3.6 Hz, 1 H, CH2), 3.72
(s, 3 H, OCH3), 3.98–4.04 (dd, J = 3.9 and 10.5 Hz, 1 H, CH2),
4.93 (q, J = 13.5 Hz, 2 H, CH2), 5.26–5.31 (m, 1 H, CH), 7.12–
7.15 (m, 3 H, HAr), 7.26 (t, J = 7.2 Hz, 1 H, HAr), 7.38–7.44 (m,
acetate/n-hexane). 1H NMR (300 MHz, CDCl3): δ = 1.15 and 1.18
(s, 9 H, CH3), 2.82–2.87 (m, 2 H, CH2), 3.36 and 3.41 (s, 3 H,
OCH3), 3.60–3.63 (m, 2 H, CH2), 4.17 (br. s, 1 H, CH), 4.68–4.91
(m, 2 H, CH and NH), 6.22–6.37 (dd, J = 7.8 Hz, 1 H, NH), 6.92–
2 H, HAr), 7.65 (d, J = 8.1 Hz, 1 H, HAr), 7.75–7.79 (m, 1 H, 7.03 (m, 4 H, HAr), 7.47–7.51 (dd, J = 2.4 and 5.4 Hz, 1 H, HAr),
HAr), 7.90–7.94 (m, 1 H, HAr), 8.05 (d, J = 6.9 Hz, 2 H, HAr) 7.83–7.92 (m, 5 H, HAr), 7.97–8.14 (m, 4 H, HAr) ppm. 13C NMR
ppm. 13C NMR (75.5 MHz, CDCl3): δ = 27.58 (CH3), 32.80 (CH2),
(75.5 MHz, CDCl3): δ = 28.15 and 28.20 (CH3), 35.64 and 35.79
52.66 (OCH3), 59.49 (CH), 66.89 (CH2), 84.00 [C(CH3)3], 123.16 (CH2), 38.36 (CH2), 52.31 and 52.34 (OCH3), 53.73 and 53.82
(CH), 123.67 (CH), 125.46 (CH), 125.76 (CH), 126.30 (CH), 127.71 (CH), 55.75 (CH), 80.22 [C(CH3)3], 122.83 and 123.02 (CH),
(CH), 128.05 (CH), 128.97 (CH), 131.91 (C), 133.37 (C), 133.82 124.75 (CH), 124.84 (C), 125.08 (C), 125.15 (CH), 125.30 (CH),
(C), 142.37 (C), 150.40 (C=O), 153.20 (C=O), 170.29 (C=O) ppm. 126.04 (CH), 126.92 (CH), 127.31 (CH), 127.44 (CH), 127.91 (CH),
HMRS (ESI): calcd. for C27H28N2NaO8 531.17434; found
531.1750.
127.44 and 128.04 (CH), 128.60 (CH), 129.27 and 129.32 (CH),
129.41 and 129.52 (C), 129.70 and 129.79 (C), 130.69 and 130.73
(C), 130.76 and 130.79 (C), 131.36 (C), 136.48 (C), 155.28 (C=O),
155.25 (C=O), 170.90 and 171.04 (C=O), 171.59 and 171.89 (C=O)
ppm. HMRS (ESI): calcd. for C34H34N2NaO5 573.23654; found
573.2374.
Methyl 3-(Naphthalen-1-yl)-2-[(4-nitrobenzyloxy)carbonylamino]-
propanoate (6): The general procedure described above was applied
with
methyl
2-[(4-nitrobenzyloxy)carbonylamino]acrylate
(0.2 mmol, 56 mg) and 1-naphthaleneboronic acid (0.8 mmol,
138 mg) to give compound 6 (69.5 mg, 85%) as a white solid. M.p.
140.0–141.0 °C (from ethyl acetate/n-hexane). 1H NMR (300 MHz,
CDCl3): δ = 3.38–3.45 (dd, J = 6.9 and 7.2 Hz, 1 H, CH2), 3.54–
3.60 (m, 4 H, OCH3 and CH2), 4.72 (d, J = 7.8 Hz, 1 H, CH), 5.07
(s, 2 H, CH2), 5.29 (d, J = 8.1 Hz, 1 H, NH), 7.14–7.19 (m, 2 H,
HAr), 7.28–7.35 (m, 2 H, HAr), 7.42–7.46 (m, 2 H, HAr), 7.71 (d,
J = 8.4 Hz, 1 H, HAr), 7.78–7.82 (m, 1 H, HAr), 7.95–8.01 (m, 1
Methyl
2-[2-(tert-Butoxycarbonylamino)propanamido]-3-(naphth-
alen-1-yl)propanoate (7): The general procedure described above
was applied with methyl 2-[2-(tert-butoxycarbonylamino)propana-
mido]acrylate (0.2 mmol, 54.5 mg) and 1-naphthaleneboronic acid
(0.8 mmol, 138 mg) to give compound 7 (57.3 mg, 72%) as an oil.
1H NMR (300 MHz, CDCl3): δ = 1.15–1.21 (m, 3 H, CH3), 1.35
(s, 9 H, CH3), 3.46–3.54 (m, 5 H, CH2 and OCH3), 4.05 (q, J =
H, HAr), 8.12 (d, J = 8.7 Hz, 2 H, HAr) ppm. 13C NMR 7.2 Hz, 1 H, CH), 4.73 (br. s, 1 H, NH), 4.85–4.94 (m, 1 H, CH),
(75.5 MHz, CDCl3): δ = 35.58 (CH2), 54.48 (OCH3), 54.74 (CH), 6.54–6.65 (dd, J = 6.9 Hz, 1 H, NH), 7.16–7.19 (m, 1 H, HAr),
65.34 (CH2), 123.28 (CH), 123.75 (CH), 125.28 (CH), 125.88 (CH), 7.31 (t, J = 8.1 Hz, 1 H, HAr), 7.38–7.51 (m, 2 H, HAr), 7.70 (d,
126.45 (CH), 127.52 (CH), 128.00 (CH), 128.16 (CH), 128.99 (CH),
J = 8.1 Hz, 1 H, HAr), 7.78 (d, J = 8.4 Hz, 1 H, HAr), 8.00–8.05
132.00 (C), 132.08 (C), 133.92 (C), 143.67 (C), 147.58 (C), 155.15 (dd, J = 3.0 and 5.4 Hz, 1 H, HAr) ppm. 13C NMR (75.5 MHz,
(C=O), 172.20 (C=O) ppm. HMRS (ESI): calcd. for CDCl3): δ = 18.17 (CH3), 28.28 and 28.30 (CH3), 35.31 and 35.46
C22H20N2NaO6 431.12191; found 431.1220.
(CH2), 52.31 (OCH3), 53.08 and 53.20 (CH), 60.44 (CH), 80.24
[C(CH3)3], 123.43 and 123.58 (CH), 125.26 and 125.29 (CH),
125.82 (CH), 126.36 and 126.44 (CH), 127.49 (CH), 128.02 and
128.05 (CH), 128.90 (CH), 132.05 and 132.16 (C), 132.20 and
132.26 (C), 13387 (C), 155.45 (C=O), 171.98 and 172.14 (C=O),
172.26 and 171.32 (C=O) ppm. HMRS (ESI): calcd. for
C22H29N2O5 401.20765; found 401.2097.
Methyl 2-[2-(tert-Butoxycarbonylamino)-3-phenylpropanamido]-3-
(naphthalen-1-yl)propanoate (4a): The general procedure described
above was applied with compound 2 (0.2 mmol, 70.0 mg) and 1-
naphthaleneboronic acid (0.8 mmol, 138 mg) to give compound 4a
(48.0 mg, 50%) as a white solid. M.p. 139.0–140.0 °C (from ethyl
1
acetate/n-hexane). H NMR (300 MHz, CDCl3): δ = 1.30 (s, 9 H,
CH3), 2.87–2.98 (m, 2 H, CH2), 3.37–3.49 (m, 5 H, CH2 and Methyl 2-[2-Bis(tert-butoxycarbonyl)amino-N-(tert-butoxycarbon-
OCH3), 4.25 (br. s, 1 H, CH), 4.79–4.86 (m, 2 H, CH and NH), yl)propanamido]-3-(naphthalen-1-yl)propanoate (8): The general
6.23–6.39 (dd, J = 7.5 Hz, 1 H, NH), 7.00–7.30 (m, 7 H, HAr),
7.40–7.51 (m, 2 H, HAr), 7.68 (d, J = 8.4 Hz, 1 H, HAr), 7.78 (d,
J = 8.7 Hz, 1 H, HAr), 7.98 (t, J = 8.7 Hz, 1 H, HAr) ppm. 13C
NMR (75.5 MHz, CDCl3): δ = 28.24 (CH3), 35.41 and 35.46
(CH2), 38.37 (CH2), 52.24 (OCH3), 53.08 and 53.26 (CH), 55.64
(CH), 80.23 [C(CH3)3], 123.37 and 123.50 (CH), 125.28 (CH),
125.82 and 125.86 (CH), 126.38 and 126.48 (CH), 126.98 (CH),
127.41 and 127.48 (CH), 128.04 and 128.09 (CH), 128.64 and
128.67 (CH), 128.92 (CH), 129.31 and 129.37 (CH), 131.98 and
132.04 (C), 132.08 and 132.12 (C), 133.90 (C), 136.49 (C), 155.28
(C=O), 170.83 and 170.96 (C=O), 171.67 and 171.97 (C=O) ppm.
HMRS (ESI): calcd. for C28H32N2NaO5 499.22089; found
499.2251.
procedure described above was followed with methyl N-(tert-bu-
toxycarbonyl)-2-[2-bis(tert-butoxycarbonyl)amino]propanamidoac-
rylate (0.2 mmol, 95 mg) and 1-naphthaleneboronic acid
(0.8 mmol, 138 mg) to give compound 8 (20.0 mg, 17%) as an oil.
1H NMR (300 MHz, CDCl3): δ = 1.40–1.44 (m, 30 H, CH3), 3.29–
3.37 (dd, J = 5.7 and 8.7 Hz, 1 H, CH2), 3.57 (s, 3 H, OCH3), 3.66
(t, J = 10.2 Hz, 1 H, CH), 3.92–3.99 (dd, J = 7.5 and 6.9 Hz, 1 H,
CH2), 5.48–5.56 (m, 1 H, CH), 7.29–7.51 (m, 4 H, HAr), 7.66 (d,
J = 8.1 Hz, 1 H, HAr), 7.77 (d, J = 6.9 Hz, 1 H, HAr), 8.11 (d, J
= 8.1 Hz, 1 H, HAr) ppm. 13C NMR (75.5 MHz, CDCl3): δ =
15.85 (CH3), 27.65 and 28.04 (CH3), 33.55 (CH2), 52.19 (OCH3),
56.98 (CH), 57.66 (CH), 82.60 and 83.85 [C(CH3)3], 124.00 (CH),
125.13 and 125.32 (CH), 125.52 (CH), 125.90 (CH), 126.16 (CH),
Eur. J. Org. Chem. 2013, 550–556
© 2013 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
555